Dosimetric analysis of LAD dose in left-sided breast cancer radiotherapy with deep inspiratory breath hold

Objectives To analyze the dose to the left anterior descending artery (LAD) in patients who have received radiotherapy for left breast cancer with Deep Inspiratory Breath Hold (DIBH) technique and compare it with other cardiac dosimetric parameters, as well as the accepted dose constraints. Materials and Methods 20 patients (10 prospective and 10 retrospective) were selected for this study. All patients underwent 2 non-contrast radiation planning CT scans of 2.5 mm thickness - one with DIBH and one with free breathing. Contouring was done using the Radiation Therapy Oncology Group (RTOG) guidelines. LAD was delineated and given a PRV of 3 mm and 5 mm. Dose-volume histograms (DVH) were used to obtain the data from the approved plans. Results The lung volume receiving 17 Gy in percentage, Dmean of the heart, LAD Dmean and Dmax, and the Dmean and Dmax received by 3 mm and 5 mm PRVs were both very well achieved when compared to the dose constraints given by the DBCG HYPO trial. The study found a higher correlation between the mean heart dose and the 5 mm PRV dose (R 2 = 0.81 and 0.71 respectively for the mean and max dose) than the 3 mm PRV, and a positive correlation between the heart dose and LAD making it a useful structure for predicting acute cardiac events. Conclusion The study of 20 patients found that DIBH is effective to minimize cardiac dose and potentially cardiac toxicity, with heart and LAD doses being comparable or lower compared to other studies. The LAD doses recorded were significantly less than those in non-DIBH studies, demonstrating the feasibility of routine contouring and recording LAD dose in left-sided breast radiation patients. Further research is needed to determine the dosimetry and clinical consequences of the Dmean and Dmax of the 5mm PRV to the LAD.